Optimal Treatment Duration of
Pseudomonas aeruginosa
allogeneic hematopoietic cell transplant recipients
duration treatment
recurrent infection
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
07
04
2020
accepted:
16
06
2020
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
25
7
2020
Statut:
epublish
Résumé
In a large, multicenter, contemporary, 8-year, cohort study, one third of allogeneic-hematopoietic cell transplant (HCT) recipients with
Identifiants
pubmed: 32704511
doi: 10.1093/ofid/ofaa246
pii: ofaa246
pmc: PMC7368374
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa246Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Clin Infect Dis. 2017 Nov 13;65(11):1819-1828
pubmed: 29020364
Clin Infect Dis. 2019 Nov 13;69(11):2011-2014
pubmed: 30882137
Haematologica. 2011 Jan;96(1):e1-3; author reply e4
pubmed: 21193424
Clin Infect Dis. 2017 Apr 1;64(7):870-876
pubmed: 28034888
Bone Marrow Transplant. 2007 Jun;39(11):687-93
pubmed: 17401395
JAMA Intern Med. 2016 Sep 1;176(9):1257-65
pubmed: 27455166
Eur J Epidemiol. 2013 Apr;28(4):347-55
pubmed: 23546766
Clin Infect Dis. 2019 Sep 13;69(7):1091-1098
pubmed: 30535100
Transplantation. 1995 Oct 15;60(7):672-8
pubmed: 7570975
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102